Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
17.53
-0.53 (-2.93%)
At close: Nov 13, 2025, 4:00 PM EST
17.60
+0.07 (0.40%)
Pre-market: Nov 14, 2025, 5:05 AM EST
Tandem Diabetes Care Analyst Ratings
Total Analysts
16
Consensus Rating
Buy
Price Target
$21.63
Upside
+23.39%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $51 → $55 | Buy | Maintains | $51 → $55 | +213.75% | Nov 10, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $13 → $17 | Hold | Maintains | $13 → $17 | -3.02% | Nov 10, 2025 |
| Truist Securities | Truist Securities | Hold Reiterates $16 → $17 | Hold | Reiterates | $16 → $17 | -3.02% | Nov 10, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $13 → $14 | Hold | Maintains | $13 → $14 | -20.14% | Nov 7, 2025 |
| Stifel | Stifel | Hold Initiates $15 | Hold | Initiates | $15 | -14.43% | Oct 21, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $14 → $16 | Hold | Maintains | $14 → $16 | -8.73% | Oct 15, 2025 |
| Citigroup | Citigroup | Hold Maintains $11 → $15 | Hold | Maintains | $11 → $15 | -14.43% | Oct 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +36.91% | Sep 29, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $44 → $22 | Buy | Maintains | $44 → $22 | +25.50% | Sep 8, 2025 |
| Citigroup | Citigroup | Hold Maintains $10 → $11 | Hold | Maintains | $10 → $11 | -37.25% | Aug 21, 2025 |
| Citigroup | Citigroup | Strong Sell → Hold Upgrades $10 → $10 | Strong Sell → Hold | Upgrades | $10 → $10 | -40.96% | Aug 12, 2025 |
| Lake Street | Lake Street | Strong Buy → Hold Downgrades $75 → $12 | Strong Buy → Hold | Downgrades | $75 → $12 | -31.55% | Aug 11, 2025 |
| Barclays | Barclays | Buy Maintains $53 → $51 | Buy | Maintains | $53 → $51 | +190.93% | Aug 8, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $59 → $24 | Strong Buy | Maintains | $59 → $24 | +36.91% | Aug 7, 2025 |
| UBS | UBS | Hold Maintains $20 → $17 | Hold | Maintains | $20 → $17 | -3.02% | Aug 7, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $45 → $25 | Buy | Maintains | $45 → $25 | +42.61% | Aug 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.